The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575
Self-citationReview of 1027 Patients With Newly Diagnosed Multiple Myeloma
Kyle, R. A., Gertz, M. A., Witzig, T. E., Lust, J. A., Lacy, M. Q., Dispenzieri, A., Fonseca, R., Rajkumar, S. V., Offord, J. R., Larson, D. R., et al. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.1.21 · Cited by 2,447
Self-citationThe International Myeloma Working Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04355.x · Cited by 2,321
Ttal, M. I. A., Ean, J., Dünne, A. A., Toppa, A. S., Ossi, R. G., Hilippe, P., Asassus, C., Acon, T. H. F., Orbert, N., Ayen, C. A. P., et al. (2013) · Cited by 2,161
BladÉ, J., Samson, D., Reece, D., Apperley, J., BJÖrkstrand, B., Gahrton, G., Gertz, M., Giralt, S., Jagannath, S., Vesole, D., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00930.x · Cited by 1,519
Self-citationMcSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,389
Self-citationEfficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A. R., Mackey, J. R., Apffelstaedt, J., Hussein, M., Coleman, R. E., Reitsma, D. J., et al. (2001) · PubMed · Cited by 896
Self-citationMajor, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H. D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.558 · Cited by 858
Orlowski, R. Z., Stinchcombe, T. E., Mitchell, B. S., Shea, T. C., Baldwin, A. S., Stahl, S., Adams, J., Esseltine, D.-L., Elliott, P. J., Pien, C. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.133 · Cited by 760
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
Barlogie, B., Smith, L., & Alexanian, R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405243102104 · Cited by 641
Katzmann, J. A., Clark, R. J., Abraham, R. S., Bryant, S. C., Lymp, J. F., Bradwell, A. R., & Kyle, R. A. (2002) · PubMed · Cited by 620
Self-citationThalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma
Weber, D., Rankin, K., Gavino, M., Delasalle, K., & Alexanian, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.139 · Cited by 566
Fermand, J.-P., Ravaud, P., Chevret, S., Divine, M., Leblond, V., Belanger, C., Macro, M., Pertuiset, E., Dreyfus, F., Mariette, X., et al. (1998) · Blood · doi:10.1182/blood.v92.9.3131 · Cited by 542
Berenson, J. R., Hillner, B. E., Kyle, R. A., Anderson, K., Lipton, A., Yee, G. C., & Biermann, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.037 · Cited by 542
Self-citationBarlogie, B., Jagannath, S., Vesole, D. H., Naucke, S., Cheson, B., Mattox, S., Bracy, D., Salmon, S., Jacobson, J., Crowley, J., et al. (1997) · Blood · doi:10.1182/blood.v89.3.789 · Cited by 541
Self-citationBarlogie, B., Desikan, R., Eddlemon, P., Spencer, T., Zeldis, J., Munshi, N., Badros, A., Zangari, M., Anaissie, E., Epstein, J., et al. (2001) · Blood · doi:10.1182/blood.v98.2.492 · Cited by 541
Self-citationCombination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma
Rajkumar, S. V., Hayman, S., Gertz, M. A., Dispenzieri, A., Lacy, M. Q., Greipp, P. R., Geyer, S., Iturria, N., Fonseca, R., Lust, J. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.116 · Cited by 512
Self-citationHIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA
MCELWAIN, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90739-0 · Cited by 510
Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens
Alexanian, R. (1969) · JAMA · doi:10.1001/jama.208.9.1680 · Cited by 499
Pasquali, S., Maqueo, J. D., Vela, J. E., Kyle, R. A., Leong, T. L., Fritz, E., Suciu, S., PALVA, I. P., Oivanen, T. M., Corrado, C., et al. (1998) · Journal of Clinical Oncology · Cited by 470
Self-citationCollapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
MARKOWITZ, G. S., APPEL, G. B., FINE, P. L., FENVES, A. Z., LOON, N. R., JAGANNATH, S., KUHN, J. A., DRATCH, A. D., & D'AGATI, V. D. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261164 · Cited by 466
Kyle, R. A., & Greipp, P. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006123022405 · Cited by 452
Self-citationErythropoietin Treatment of Anemia Associated with Multiple Myeloma
Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gisslinger, H., & Barnas, U. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222402 · Cited by 443
Self-citationDrayson, M., Tang, L. X., Drew, R., Mead, G. P., Carr-Smith, H., & Bradwell, A. R. (2001) · Blood · doi:10.1182/blood.v97.9.2900 · Cited by 419
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00071.x · Cited by 384
Mandelli, F., Avvisati, G., Amadori, S., Boccadoro, M., Gernone, A., Lauta, V. M., Marmont, F., Petrucci, M. T., Tribalto, M., Vegna, M. L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222005 · Cited by 382
Self-citationPrimary dexamethasone treatment of multiple myeloma
Alexanian, R., Dimopoulos, M., Delasalle, K., & Barlogie, B. (1992) · Blood · doi:10.1182/blood.v80.4.887.887 · Cited by 366
Bjorkstrand, B., Ljungman, P., Svensson, H., Hermans, J., Alegre, A., Apperley, J., Blade, J., Carlson, K., Cavo, M., Ferrant, A., et al. (1996) · Blood · doi:10.1182/blood.v88.12.4711.bloodjournal88124711 · Cited by 356
Self-citationGahrton, G., Svensson, H., Cavo, M., Apperley, J., Bacigalupo, A., Björkstrand, B., Bladé, J., Cornelissen, J., De Laurenzi, A., Facon, T., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02726.x · Cited by 340
Self-citationDesikan, R., Barlogie, B., Sawyer, J., Ayers, D., Tricot, G., Badros, A., Zangari, M., Munshi, N. C., Anaissie, E., Spoon, D., et al. (2000) · Blood · doi:10.1182/blood.v95.12.4008 · Cited by 320
Self-citationLenhoff, S., Hjorth, M., Holmberg, E. C., Turesson, I., Westin, J., Nielsen, J. L., Wislöff, F., Brinch, L., Carlson, K. E., Carlsson, M. S., et al. (2000) · PubMed · doi:10.1182/blood.v95.1.7 · Cited by 310
VAD‐based regimens as primary treatment for multiple myeloma
Alexanian, R., Barlogie, B., & Tucker, S. (1990) · American Journal of Hematology · doi:10.1002/ajh.2830330203 · Cited by 307
Biology of Osteoclast Activation in Cancer
Roodman, G. D. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3562 · Cited by 306
Results of autologous stem cell transplant in multiple myeloma patients with renal failure
Badros, A., Barlogie, B., Siegel, E., Roberts, J., Langmaid, C., Zangari, M., Desikan, R., Shaver, M. J., Fassas, A., McConnell, S., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03033.x · Cited by 306
Self-citationYaccoby, S., Pearse, R. N., Johnson, C. L., Barlogie, B., Choi, Y., & Epstein, J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03257.x · Cited by 305
Whole-body (18)F-FDG PET identifies high-risk myeloma.
Durie, B. G. M., Waxman, A. D., D'Agnolo, A., & Williams, C. M. (2002) · PubMed · Cited by 272
Self-citationJohnson, W. J., Kyle, R. A., Pineda, A. A., O'Brien, P. C., & Holley, K. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.863 · Cited by 265
Self-citationPretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma
Durie, B., Salmon, S., & Moon, T. (1980) · Blood · doi:10.1182/blood.v55.3.364.364 · Cited by 262
Self-citationChapel, H. M., Lee, M., Hargreaves, R., Pamphilon, D. H., Prentice, A. G., Chapel, H. M., Hargreaves, R., Lee, M., Pamphilon, D. H., & Prentice, A. G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90180-5 · Cited by 260
Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients
Berenson, J. R., Crowley, J. J., Grogan, T. M., Zangmeister, J., Briggs, A. D., Mills, G. M., Barlogie, B., & Salmon, S. E. (2002) · Blood · doi:10.1182/blood.v99.9.3163 · Cited by 240
Corradini, P., Voena, C., Tarella, C., Astolfi, M., Ladetto, M., Palumbo, A., Van Lint, M. T., Bacigalupo, A., Santoro, A., Musso, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.208 · Cited by 237
Self-citation[Renal failure in multiple myeloma].
Sicinski, A. M. (1986) · PubMed · Cited by 223
Hjorth, M., Hellquist, L., Holmberg, E., Magnusson, B., Rödjer, S., & Westin, J. (1993) · European Journal of Haematology · doi:10.1111/j.1600-0609.1993.tb00148.x · Cited by 220
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]
Ludwig, H., Fritz, E., Leitgeb, C., Pecherstorfer, M., Samonigg, H., & Schuster, J. (1994) · Blood · doi:10.1182/blood.v84.4.1056.1056 · Cited by 196
Self-citationCunningham, D., Powles, R., Malpas, J., Raje, N., Milan, S., Viner, C., Montes, A., Hickish, T., Nicolson, M., Johnson, P., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00795.x · Cited by 168
Self-citationCallander, N. S., & Roodman, G. D. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90020-4 · Cited by 166
Fritz, E., & Ludwig, H. (2000) · Annals of Oncology · doi:10.1023/a:1026548226770 · Cited by 163
Self-citationPrognostic factors and staging in multiple myeloma: a reappraisal.
Bataille, R., Durie, B. G., Grenier, J., & Sany, J. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.1.80 · Cited by 163
Self-citationDouble-intensive therapy in high-risk multiple myeloma
Harousseau, J., Milpied, N. J., Laporte, J. P., Collombat, P., Facon, T. T. F., Tigaud, J. D., Casassus, P., Guilhot, F., Ifrah, N., & Gandhour, C. (1992) · Blood · doi:10.1182/blood.v79.11.2827.2827 · Cited by 147
CLINICAL EXPERIENCES WITH SARCOLYSIN IN NEOPLASTIC DISEASES
Blokhin, N. N., Lf, L., Переводчикова, Н. И., Chebotareva, L., & Merkulova, N. A. (1958) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1958.tb42675.x · Cited by 140
Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis
MacLennan, I. C. M., Chapman, C. E., Dunn, J., & Kelly, K. A. (1992) · The Lancet · doi:10.1016/0140-6736(92)90004-m · Cited by 139
Xavier Mariette, A., Zagdanski, A., Guermazi, A., Bergot, C., Arnould, A., Frija, J., Brouet, J. C., & Fermand, J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01244.x · Cited by 127
Riccardi, A., Mora, O., Tinelli, C., Valentini, D., Brugnatelli, S., Spanedda, R., Paoli, A. D., Barbarano, L., Stasi, M., Giordano, M., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1087 · Cited by 124
Peters, T. J. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.1.107-b · Cited by 123
Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple Myeloma
Durie, B. G. M., Salmon, S. E., & Mundy, G. R. (1981) · British Journal of Haematology · doi:10.1111/j.1365-2141.1981.tb02758.x · Cited by 120
Self-citationJacobson, J. L., Hussein, M. A., Barlogie, B., Durie, B. G. M., & Crowley, J. J. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04456.x · Cited by 119
Self-citationThe role of autologous transplantation in patients with multiple myeloma aged 65 years and over
Sirohi, B., Powles, R., Treleaven, J. G., Mainwaring, P. N., Kulkarni, S., Pandha, H. S., Bhagwati, N., Horton, C., Singhal, S., & Mehta, J. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702188 · Cited by 116
Self-citationCurrent Therapy for Multiple Myeloma
Rajkumar, S. V., Gertz, M. A., Kyle, R. A., & Greipp, P. R. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.8.813 · Cited by 107
Self-citationTricot, G. J. K., Spencer, T., Sawyer, J. R., Spoon, D., Desikan, R. K., Fassas, A., Badros, A. Z., Zangari, M., Munshi, N. C., Anaissie, E. J., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03231.x · Cited by 89
Self-citationGahrton, G., Svensson, H., Björkstrand, B., Apperley, J. F., Carlson, K. E., Cavo, M., Ferrant, A., Fouillard, L., Gratecos, N., Gratwohl, A. A., et al. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701975 · Cited by 84
Self-citationMagnetic resonance imaging patterns in patients with multiple myeloma
KUSUMOTO, S., Jinnai, I., Itoh, K., Kawai, N., Sakata, T., Matsuda, A., Tominaga, K., MUROHASHI, I., Bessho, M., Harashima, K., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4213236.x · Cited by 64
Cyclophosphamide vs Melphalan in Treatment of Plasma Cell Myeloma
Rivers, S. L. (1969) · JAMA · doi:10.1001/jama.1969.03150200094011 · Cited by 59
Musto, P., Falcone, A. P., D'Arena, G. F., Scalzulli, P. R., Matera, R., Minervini, M. M., Lombardi, G., Modoni, S., Longo, A., & Carotenuto, M. (1997) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1997.tb01677.x · Cited by 55
Oken, M. M., Leong, T. L., Lenhard, R. E., Greipp, P. R., Kay, N. E., Ness, B. V., Keimowitz, R. M., & Kyle, R. A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990915)86:6<957::aid-cncr10>3.0.co;2-8 · Cited by 50
Self-citationPlasma cell dyscrasias: Current status
Kyle, R. A., & Greipp, P. A. (1988) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(88)80008-8 · Cited by 41
Self-citationImrie, K., Esmail, R., Meyer, R. M., & and the Members of the Hematology Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00012 · Cited by 40
Low-dose thalidomide in myeloma: Efficacy and biologic significance
Durie, B. G. M. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70059-6 · Cited by 38
Self-citationThe Role of Bisphosphonates in Multiple Myeloma
Kyle, R. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00009 · Cited by 31
Self-citationCost‐effectiveness of high‐dose chemotherapy in first‐line treatment of advanced multiple myeloma
Sampson, F. C., Beard, S. M., Scott, F., & Vandenberghe, E. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02854.x · Cited by 24
Yussim, E., Schwartz, E., Sidi, Y., & Ehrenfeld, M. (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199806)58:2<142::aid-ajh10>3.0.co;2-d · Cited by 17
Durie, B. G. M. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057895 · Cited by 9
Self-citationDurie, B. G. M., & Salmon, S. E. (1975) · Cancer · doi:10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u
Self-citation
Cited by
International Staging System for Multiple Myeloma
Greipp, P. R., Miguel, J. S., Durie, B. G. M., Crowley, J. J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J. A., Avet-Loiseau, H., Kyle, R. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.242 · Cited by 2,974
Self-citationPalumbo, A., & Anderson, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,326
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Durie, B. G. M., Hoering, A., Abidi, M. H., Rajkumar, S. V., Epstein, J., Kahanic, S. P., Thakuri, M., Reu, F., Reynolds, C. M., Sexton, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31594-x · Cited by 908
Self-citationPalumbo, A., Bringhen, S., Caravita, T., Merla, E., Capparella, V., Callea, V., Cangialosi, C., Grasso, M., Rossini, F., Galli, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68338-4 · Cited by 809
Self-citation
Metadata
- Authors
- Durie, B. G. M., Kyle, R. A., Belch, A., Bensinger, W., Blade, J., Boccadoro, M., Anthony Child, J., Comenzo, R., Djulbegovic, B., Fantl, D., Gahrton, G., Luc Harousseau, J., Hungria, V., Joshua, D., Ludwig, H., Mehta, J., Rodrique Morales, A., Morgan, G., Nouel, A., Oken, M., Powles, R., Roodman, D., San Miguel, J., Shimizu, K., Singhal, S., Sirohi, B., Sonneveld, P., Tricot, G., & Van Ness, B.
- Venue
- The Hematology Journal
- Published
- 2003
- Volume
- 4
- Issue
- 6
- Pages
- 379-398
- ISSN
- 1466-4860 (ISSN-L)
- 1476-5632
- OpenAlex
- W2144129115
- Cited by
- 427
- References
- 74
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.